Belite Bio, Inc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Belite Bio, Inc (BLTE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $8.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $8.09M 20-F · filed 2026-03-31 |
| 2024-12-31 | $4.88M 20-F · filed 2026-03-31 |
| 2023-12-31 | $3.79M 20-F · filed 2025-03-17 |
| 2022-12-31 | $1.17M 20-F · filed 2024-03-12 |